| Identification | Back Directory | [Name]
N-(L-Lac-N-Methyl-D-Leu-)cyclo[L-Thr*-[(3S,4R)-3-hydroxy-4-[(S)-1-methylpropyl]-γAbu-]-[(2S,4S)-4-hydroxy*-2,5-dimethyl-2-deamino-3-oxo-D-Nle-]-L-Leu-L-Pro-N,O-dimethyl-L-Tyr-] | [CAS]
77327-06-1 | [Synonyms]
Didemnin C
N-(L-Lac-N-Methyl-D-Leu-)cyclo[L-Thr*-[(3S,4R)-3-hydroxy-4-[(S)-1-methylpropyl]-γAbu-]-[(2S,4S)-4-hydroxy*-2,5-dimethyl-2-deamino-3-oxo-D-Nle-]-L-Leu-L-Pro-N,O-dimethyl-L-Tyr-]
L-Tyrosine, N-[(2S)-2-hydroxy-1-oxopropyl]-N-methyl-D-leucyl-L-threonyl-(3S,4R,5S)-4-amino-3-hydroxy-5-methylheptanoyl-(2S,4S)-4-hydroxy-2,5-dimethyl-3-oxohexanoyl-L-leucyl-L-prolyl-N,O-dimethyl-, (7→2)-lactone | [Molecular Formula]
C52H82N6O14 | [MOL File]
77327-06-1.mol | [Molecular Weight]
1015.26 |
| Hazard Information | Back Directory | [Uses]
Didemnin C is a cyclic depsipeptide that can be used as an anti-neoplastic agent[1]. | [References]
[1] Crampton SL, et al. Biochemical and cellular effects of didemnins A and B. Cancer Res. 1984 May;44(5):1796-801. PMID:6713383 |
|
|